A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors

Clinical trial NCT06143007 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06143007
Sponsor: Broadenbio Ltd., Co.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-10-26
Primary completion: 2025-05-22
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.